• ⌘ + K
  • Home
  • 0
    Inbox
Explore
  • Browse All
  • Health
  • FedCiv
  • Defense
  • Events
Work
  • Teaming Hub
  • Watchlists
  • Bookmarks
  • Notes
Research
  • Grants
    • Contracts
    • Vehicles
    • OTAs
    • OTIDVs
    • DLA DIBBS
    • SBIR/STTR
  • Agencies
  • NAICS
  • PSC
  • DOGE Tracker

Federal Contract Awards

22awards

Analyze awards, watch incumbents and competitors, track new transactions or changes, and use award history to shape recompete and capture strategy.

Awardee
is
MGXADJ6SCLJ5
Award ID
Description
Recipient
Total Value
Awarding Agency
Funding Agency
Set Aside
NAICS
PSC
Award Date
Start Date
End Date
36C24926F0152
EMERGENCY ORLADEYOBIOCRYST PHARMACEUTICALS INC$30,293VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSMay 21, 2026May 21, 2026Jun 10, 2026
36C26026F0294
ORLADEYO 150MG CAPBIOCRYST PHARMACEUTICALS INC$151,465VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSMay 19, 2026May 19, 2026Sep 30, 2026
36C26026F0006
PHARM - ORLADEYOBIOCRYST PHARMACEUTICALS INC$360,000VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSOct 1, 2025Oct 1, 2025Sep 30, 2026
36C26025F0296
BULK ORDER ORLADEYO FOR VETERAN CARE.BIOCRYST PHARMACEUTICALS INC$29,408VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSJun 18, 2025Sep 9, 2025Sep 8, 2026
36C26025F0070
BULK ORLADEYO PHARMACEUTICALBIOCRYST PHARMACEUTICALS INC$242,987VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSNov 4, 2024Mar 12, 2025Mar 11, 2026
36C26025F0024
BEROTRALSTAT HCL 150MG CAP,ORAL (ORLADEYO).BIOCRYST PHARMACEUTICALS INC$379,939VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSOct 1, 2024Oct 1, 2024Sep 30, 2025
75A50324F80012
PERAMIVIR (RAPIVAB 200MG/20ML (10MG/ML INJ SOLN))BIOCRYST PHARMACEUTICALS INC$69,388,369OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSEOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSSep 23, 2024Sep 30, 2024Sep 29, 2025
36C26024F0625
BEROTRALSTAT HCL 150MG CAP,ORAL TRADE NAME: ORLADEYO 150MG CAPBIOCRYST PHARMACEUTICALS INC$379,349VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSSep 9, 2024Sep 9, 2024Sep 8, 2025
36C26024F0270
BULK ORDER ORLADEYOBIOCRYST PHARMACEUTICALS INC$357,245VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSMar 12, 2024Mar 12, 2024Mar 11, 2025
36C26024F0258
ORLADEYO 150MG CAPSBIOCRYST PHARMACEUTICALS INC$201,722VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSMar 1, 2024Mar 4, 2024Oct 4, 2024
36C26024F0240
ORLADEYO EMERGENTBIOCRYST PHARMACEUTICALS INC$29,650VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSFeb 20, 2024Feb 20, 2024May 20, 2024
36C26124N0446
BEROTRALSTATBIOCRYST PHARMACEUTICALS INC$0VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSFeb 16, 2024Feb 16, 2024May 16, 2024
36C26023F0144
BEROTRALSTATBIOCRYST PHARMACEUTICALS INC$56,671VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSJan 20, 2023Jan 20, 2023Jan 19, 2024
36C26022F0215
BEROTRALSTAT HCL 150MG CAP,ORAL BULK, 72769-0101-01BIOCRYST PHARMACEUTICALS INC$113,441VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSMay 20, 2022Jun 1, 2022May 31, 2023
36C26022F0188
BEROTRALSTAT (ORLADEYO) 150MGBIOCRYST PHARMACEUTICALS INC$85,081VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSMar 8, 2022Mar 8, 2022Jun 30, 2022
75N93020C00055
COVID-19. TO MANUFACTURE AND EVALUATE THE SAFETY, EFFICACY AND TOLERABILITY OF GALIDESIVIR A BROAD SPECTRUM, ANTIVIRAL THERAPEUTIC.BIOCRYST PHARMACEUTICALS INC$40,195,775NATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH—541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)AJ12GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCHAug 31, 2020Sep 1, 2020Sep 30, 2022
75D30118C02984
PERAMIVIR, RAPIVAB FLU TREATMENTBIOCRYST PHARMACEUTICALS INC$34,660,000OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSEOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSAug 30, 2018Sep 1, 2018Aug 31, 2023
HHSO100201500007C
IGF::CT::IGF BIOCRYST PHARMACEUTICALSBIOCRYST PHARMACEUTICALS INC$11,911,994OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSEOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE—541711AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENTMar 27, 2015Mar 31, 2015May 31, 2021
HHSO100201400011A
IGF::OT::IGF PERAMIVIR STABILITY EXTENSION PROGRAMBIOCRYST PHARMACEUTICALS INC$134,064OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSEOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE—541711AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENTJun 27, 2014Jun 27, 2014Mar 31, 2020
HHSN272201300017C
IGF::OT::IGF - DEVELOPMENT OF MEDICAL COUNTERMEASURES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES, BASE, OPTION 1 AND OPTION 2 AWARD, 09/16/2013 - 09/15/2017BIOCRYST PHARMACEUTICALS INC$47,755,723NATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH—541711AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCHSep 12, 2013Sep 16, 2013Sep 30, 2022
HHSO10033001T
DRUGS AND BIOLOGICALSBIOCRYST PHARMACEUTICALS INC$22,500,000OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSEOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE—325412Pharmaceutical Preparation Manufacturing6505DRUGS AND BIOLOGICALSNov 4, 2009Nov 4, 2009Nov 2, 2011
HHSO100200700032C
ADVANCE DEVELOPMENT OF NEW ANTIVIRAL AGENT FOR INFLUENZABIOCRYST PHARMACEUTICALS INC$204,984,699OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSEOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE—541710AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENTJan 3, 2007Jan 3, 2007Apr 30, 2014
Page 1 of 1
  • Previous
  • Next